what we research

Stem Cell Therapy and Genetic Engineering

1.

Targeted Immunotherapy in Leukemia Patients

2.

Neuroblastoma Outcome Improvements

3.

Developmental & Experimental Therapeutics

4.

Sickle Cell Disease and Hemophilia

5.

Pediatric Bleeding and Thrombosis Disorders

6.

mITCHELL s. cAIRO, md

Dr. Cairo has been an international leader in basic, translational and clinical research in childhood, adolescent and young adults with an emphasis in stem cell transplantation, stem cell biology, lymphoma, tumor immunology, and developmental therapeutics.

 

the research team

Leading clinical trials in Stem Cell Therapy and Genetic Engineering to reduce toxicity during and after transplant and improve cure rates for high-risk disease.

Allyson Flower, MD

Developing targeted immunotherapy to improve outcomes in leukemia and lymphoma while reducing long term side effects.

jessica hochberg, MD

Researching ways to improve outcome of Neuroblastoma and other solid tumors using immune checkpoint inhibition.

mehmet fevzi ozkaynak, md

Developing a program in personalized cancer medicine to treat refractory and recurrent solid tumors.

jeremy rosenblum, md

A leader in the treatment of children, adolescents and young adults with Sickle Cell Disease and Hemophilia investigating ways to reduce complications, improve Quality of Life and obtain a cure.

claudio sandoval, md

Specializes in the treatment of pediatric bleeding and thrombosis disorders, leading a clinical trial with a novel oral anticoagulant.

oya levendoglu-Tugal, md